Liquid Biopsy for Breast Cancer Surveillance 2026
Post Operative Monitoring for Minimal Residual Disease in Patients Breast cancer treatment has come a long way, but the fear of recurrence remains a major concern for many survivors. In 2026, blood-based testing is being used to provide peace of mind and improve long-term outcomes. For patients who have undergone surgery and radiation, regular blood draws can look for circulating tumor DNA that...
0 Commentarii 0 Distribuiri 18 Views 0 previzualizare